NCT06309654

Brief Summary

Background: Obesity and type 2 diabetes mellitus (T2DM) are considered two of the most prevalent metabolic diseases linked to the onset of knee pain caused by osteoarthritis. Regular exercise has been documented as a principal component of a prevention, management, and treatment strategy for knee osteoarthritis (KOA) patients. However, evidence-based exercise protocols for individuals with comorbidities such as obesity, T2DM, and KOA are scarce. Thus, the present pragmatic randomized controlled trial aimed to investigate the effectiveness of a 12-week home-based circuit training (HBCT) protocol on various indicators related to KOA and cardiometabolic health among overweight/obese older adult patients with KOA and T2DM during the COVID-19 lockdown. Methods: Seventy overweight or obese patients with KOA and T2DM (62.2 ± 6.1 years; 56% female) were randomly assigned to the intervention group (n = 35, HBCT) or the no-exercise control group (n = 35, CON). HBCT performed a progressive protocol (seven exercises; 15-30 repetitions per exercise, 1 min passive rest between exercises; 2-4 rounds per session; 20-60 min total session duration). The knee injury and osteoarthritis symptoms, cardiovascular and metabolic risk factors, cardiorespiratory fitness, and renal function were assessed at baseline and following the 12-week intervention. Results: HBCT significantly improved HBCT improved the vast majority of outcomes related to cardiometabolic health and knee osteoarthritis symptoms compared to CON (p\<0.05). No significant differences were detected in total bilirubin, sodium, urea, resting heart rate, or KOOS-sport between HBCT and CON. Conclusion: These findings suggest that an injury-free HBCT program may improve several cardiometabolic health- and KOA-related indices in overweight/obese patients with T2DM and KOA. Such results may encourage clinicians and practitioners to adopt real-world exercise training approaches when prescribing physical exercise to patients characterized by impaired metabolic and musculoskeletal health.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 13, 2021

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 13, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 29, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 1, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 13, 2024

Completed
Last Updated

March 13, 2024

Status Verified

March 1, 2024

Enrollment Period

2 years

First QC Date

March 1, 2024

Last Update Submit

March 7, 2024

Conditions

Outcome Measures

Primary Outcomes (6)

  • Blood pressure

    systolic (SBP) and diastolic (DBP) blood pressure

    end of 12 week

  • The A1C test

    end of 12 week

  • blood oxygen levels

    oxygen level was quantify using SpO2

    end of 12 week

  • cardiorespiratory fitness

    a 6-minute walk test (6MWT)

    end of 12 week

  • interleukin 6 (IL-6)

    an interleukin that acts as both a pro-inflammatory cytokine and an anti-inflammatory myokine will be measured using Human ELISA Kit #P05231 and # P00441, respectively

    end of 12 week

  • Superoxide dismutases (SOD)

    enzyme that alternately catalyzes the dismutation (or partitioning) of the superoxide will be measured using g Plasma IL-6 and SOD levels

    end of 12 week

Study Arms (2)

home-based circuit training (HBCT) protocol

EXPERIMENTAL

Participants in the exercise group performed HBCT three times per week on non-consecutive days for 12 weeks.

Behavioral: 12-week home-based circuit training (HBCT)

Standard of care (CONT)

SHAM COMPARATOR

Providing education about the nature of OA, its progression, and strategies for symptom management. Empowering individuals with self-management techniques, such as joint protection strategies, activity modification, and lifestyle changes (e.g., weight management, exercise).

Behavioral: Standard of care (CONT)

Interventions

Participants in the exercise group performed HBCT three times per week on non-consecutive days for 12 weeks. The first session was conducted at USM Hospital and participants were instructed how to perform the prescribed exercises in a correct form. In each session, participants performed seven exercises (two aerobic- and five resistance-based) in a circuit fashion, using bodyweight movements and adjustable dumbbells for varied weights, activating all the major muscle groups. In weeks 1-6, participants executed 15 repetitions for 2 rounds with 1 min passive rest between exercises and rounds. In weeks 7-12, participants executed 30 repetitions for 4 rounds with the same rest as prescribed in weeks 1-6. Each round lasted 10-15 min and the total session duration was 20-60 min, aiming to help participants adapt gradually to increasing training volume.

home-based circuit training (HBCT) protocol

Providing education about the nature of OA, its progression, and strategies for symptom management. Empowering individuals with self-management techniques, such as joint protection strategies, activity modification, and lifestyle changes (e.g., weight management, exercise).

Standard of care (CONT)

Eligibility Criteria

Age55 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age \>55 years
  • diagnosed with KOA with Kellgren-Lawrence criteria grades 2 and 3, indicating moderate KOA, which was based on radiological assessments conducted by a traumatologist
  • chronic knee pain for more than three months
  • T2DM based on fasting plasma glucose \>7.0 mmol·L-1 and glycated hemoglobin (HbA1c) \>6.5%,
  • overweight or obesity (BMI ≥25 kg/m2)
  • providing a certificate of a negative COVID-19 diagnostic test (PCR or rapid test).

You may not qualify if:

  • secondary KOA
  • acute knee pain,
  • changes in medication, supplementation, and/or diet
  • changes in habitual physical activity
  • smoking
  • dementia or any psychiatric diseases
  • adherence to less than 90% of total prescribed exercise sessions
  • tested positive for COVID-19

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Princess Nourah bint Abdulrahman University

Riyadh, 11671, Saudi Arabia

Location

MeSH Terms

Conditions

Metabolic Syndrome

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Insulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Sameer Al-Mhanna, Phd

    Department of physiology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian 16150, Kelantan, Malaysia

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Seventy overweight or obese patients with KOA and T2DM (62.2 ± 6.1 years; 56% female) were randomly assigned to the intervention group (n = 35, HBCT) or the no-exercise control group (n = 35, CON). HBCT performed a progressive protocol (seven exercises; 15-30 repetitions per exercise, 1 min passive rest between exercises; 2-4 rounds per session; 20-60 min total session duration). The knee injury and osteoarthritis symptoms, cardiovascular and metabolic risk factors, cardiorespiratory fitness, and renal function were assessed at baseline and following the 12-week intervention.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

March 1, 2024

First Posted

March 13, 2024

Study Start

September 13, 2021

Primary Completion

September 13, 2023

Study Completion

December 29, 2023

Last Updated

March 13, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations